These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 9777413

  • 1. C1q as antigen in humoral autoimmune responses.
    Siegert CE, Daha MR.
    Immunobiology; 1998 Aug; 199(2):295-302. PubMed ID: 9777413
    [Abstract] [Full Text] [Related]

  • 2. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC, Zhou B, Dong Y.
    Zhonghua Yi Xue Za Zhi; 2005 Apr 13; 85(14):955-9. PubMed ID: 16061001
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
    Siegert CE, Daha MR, Tseng CM, Coremans IE, van Es LA, Breedveld FC.
    Ann Rheum Dis; 1993 Dec 13; 52(12):851-6. PubMed ID: 8311534
    [Abstract] [Full Text] [Related]

  • 4. IgG autoantibodies to C1q do not detectably influence complement activation in vivo and in vitro in systemic lupus erythematosus.
    Siegert CE, Daha MR, Lobatto S, van der Voort EA, Breedveld FC.
    Immunol Res; 1992 Dec 13; 11(2):91-7. PubMed ID: 1431425
    [Abstract] [Full Text] [Related]

  • 5. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C, Daha M, Westedt ML, van der Voort E, Breedveld F.
    J Rheumatol; 1991 Feb 13; 18(2):230-4. PubMed ID: 2023216
    [Abstract] [Full Text] [Related]

  • 6. C1q and systemic lupus erythematosus.
    Walport MJ, Davies KA, Botto M.
    Immunobiology; 1998 Aug 13; 199(2):265-85. PubMed ID: 9777411
    [Abstract] [Full Text] [Related]

  • 7. Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.
    Thanei S, Vanhecke D, Trendelenburg M.
    Clin Immunol; 2015 Oct 13; 160(2):180-7. PubMed ID: 26148903
    [Abstract] [Full Text] [Related]

  • 8. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y, Yang XW, Song Y, Yu F, Zhao MH.
    Immunobiology; 2014 Dec 13; 219(12):980-9. PubMed ID: 25092568
    [Abstract] [Full Text] [Related]

  • 9. IgG and IgA autoantibodies to C1q in systemic and renal diseases.
    Siegert CE, Daha MR, Halma C, van der Voort EA, Breedveld FC.
    Clin Exp Rheumatol; 1992 Dec 13; 10(1):19-23. PubMed ID: 1348021
    [Abstract] [Full Text] [Related]

  • 10. Antibodies against C1q in patients with systemic lupus erythematosus.
    Trendelenburg M.
    Springer Semin Immunopathol; 2005 Nov 13; 27(3):276-85. PubMed ID: 16189648
    [Abstract] [Full Text] [Related]

  • 11. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E, Tănăsescu C, Bălănescu P, Olteanu R, Badea C, Petruţescu B, Grancea C, Vagu C, Bleotu C, Ruţă S, Ardeleanu C.
    Rom J Intern Med; 2010 Nov 13; 48(2):159-63. PubMed ID: 21428180
    [Abstract] [Full Text] [Related]

  • 12. IgG subclass restriction of autoantibody to solid-phase C1q in membranoproliferative and lupus glomerulonephritis.
    Prada AE, Strife CF.
    Clin Immunol Immunopathol; 1992 Apr 13; 63(1):84-8. PubMed ID: 1591887
    [Abstract] [Full Text] [Related]

  • 13. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
    Gunnarsson I, Rönnelid J, Huang YH, Rogberg S, Nilsson B, Lundberg I, Klareskog L.
    Br J Rheumatol; 1997 Jan 13; 36(1):32-7. PubMed ID: 9117171
    [Abstract] [Full Text] [Related]

  • 14. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E, Kralikova P.
    Scand J Immunol; 2008 May 13; 67(5):423-30. PubMed ID: 18363591
    [Abstract] [Full Text] [Related]

  • 15. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P, Deliyska B, Fünfstück R, Hein G, Herrmann D, Stein G.
    Clin Rheumatol; 2003 Oct 13; 22(4-5):271-8. PubMed ID: 14576989
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic and prognostic significance of anti-C1q antibodies in systemic lupus erythematosus.
    Seelen MA, Trouw LA, Daha MR.
    Curr Opin Nephrol Hypertens; 2003 Nov 13; 12(6):619-24. PubMed ID: 14564199
    [Abstract] [Full Text] [Related]

  • 17. Anti-C1q antibodies: a biomarker for diagnosis and management of lupus nephritis. A narrative review.
    Calatroni M, Moroni G, Conte E, Stella M, Reggiani F, Ponticelli C.
    Front Immunol; 2024 Nov 13; 15():1410032. PubMed ID: 38938561
    [Abstract] [Full Text] [Related]

  • 18. Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis.
    Jaekell HP, Trabandt A, Grobe N, Werle E.
    Lupus; 2006 Nov 13; 15(6):335-45. PubMed ID: 16830879
    [Abstract] [Full Text] [Related]

  • 19. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Nov 13; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C, Olin AI, Skogh T, Wetterö J, Mörgelin M, Nived O, Sturfelt G, Bengtsson AA.
    Autoimmunity; 2013 May 13; 46(3):205-14. PubMed ID: 23331132
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.